Cargando…
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
PURPOSE: The value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-positron emission tomography (PET)-radiomics in the outcome assessment of patients with recurrent glioblastoma (rGBM) has not been evaluated until now. The aim of this study was to evaluate whether a prognostic model based on FET-PET radi...
Autores principales: | Carles, Montserrat, Popp, Ilinca, Starke, Michael Maximilian, Mix, Michael, Urbach, Horst, Schimek-Jasch, Tanja, Eckert, Franziska, Niyazi, Maximilian, Baltas, Dimos, Grosu, Anca L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931514/ https://www.ncbi.nlm.nih.gov/pubmed/33658069 http://dx.doi.org/10.1186/s13014-020-01744-8 |
Ejemplares similares
-
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
por: Carles, Montserrat, et al.
Publicado: (2021) -
(18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
por: Wiltgen, Tun, et al.
Publicado: (2022) -
Experimental phantom evaluation to identify robust positron emission tomography (PET) radiomic features
por: Carles, Montserrat, et al.
Publicado: (2021) -
Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking
por: Popp, Ilinca, et al.
Publicado: (2022) -
(18)F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
por: Carles, Montserrat, et al.
Publicado: (2021)